- call +1-201-465-4211
- email sales@mrinsights.biz
ADME testing refers to the pharmacokinetic testing of a compound in living organism and known as ADME/Tox. Drug development is a cost and time intensive process. The traditional drug development process includes toxicity and efficacy testing in in-vivo environment which is responsible for late stage failure of drugs in human body, as the results observed in animal models and human are different. To overcome this drug failure hurdle drug manufacturers are incorporating ADME toxicity testing in early drug developmental phases.
Scope of the Report:
This report studies the ADME Toxicology Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the ADME Toxicology Testing market by product type and applications/end industries.
Geographically, North America is expected to have the largest market share in terms of revenue followed by Europe during the forecast period. Larger base of drug manufacturing organizations coupled with supportive government regulations pertaining to drug development are key drivers for the growth of this regional market. Additionally, increasing R&D investments related to drug discovery is also expected to propel growth of this market. Asia Pacific is expected to have a lucrative growth owing to rapidly improving healthcare infrastructure, rising spending in healthcare & diagnostic centers, increasing patient awareness levels and increased access to healthcare services in the emerging economies of India and China.
The global ADME Toxicology Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of ADME Toxicology Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Accelrys (Dassault Systemes)
Agilent Technologies
Bio-Rad Laboratories
Promega
Sigma Aldrich
Thermo Fisher Scientific
Cyprtorex
CytoPulse
Entelos
LI-COR Biosciences
Mattek
Miltenyi Biotec
Molecular Toxicology
Quintiles
RTI Health Solutions
SBW
Xenobiotic Detection Systems
Xenometrix
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Toxicology Testing
ADME Testing
Market Segment by Applications, can be divided into
In Vivo
In Vitro
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 ADME Toxicology Testing Market Overview
1.1 Product Overview and Scope of ADME Toxicology Testing
1.2 Classification of ADME Toxicology Testing by Types
1.2.1 Global ADME Toxicology Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global ADME Toxicology Testing Revenue Market Share by Types in 2017
1.2.3 Toxicology Testing
1.2.4 ADME Testing
1.3 Global ADME Toxicology Testing Market by Application
1.3.1 Global ADME Toxicology Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 In Vivo
1.3.3 In Vitro
1.4 Global ADME Toxicology Testing Market by Regions
1.4.1 Global ADME Toxicology Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) ADME Toxicology Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) ADME Toxicology Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) ADME Toxicology Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) ADME Toxicology Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) ADME Toxicology Testing Status and Prospect (2013-2023)
1.5 Global Market Size of ADME Toxicology Testing (2013-2023)
2 Manufacturers Profiles
2.1 Accelrys (Dassault Systemes)
2.1.1 Business Overview
2.1.2 ADME Toxicology Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Accelrys (Dassault Systemes) ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Agilent Technologies
2.2.1 Business Overview
2.2.2 ADME Toxicology Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Agilent Technologies ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bio-Rad Laboratories
2.3.1 Business Overview
2.3.2 ADME Toxicology Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bio-Rad Laboratories ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Promega
2.4.1 Business Overview
2.4.2 ADME Toxicology Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Promega ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sigma Aldrich
2.5.1 Business Overview
2.5.2 ADME Toxicology Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sigma Aldrich ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific
2.6.1 Business Overview
2.6.2 ADME Toxicology Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cyprtorex
2.7.1 Business Overview
2.7.2 ADME Toxicology Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cyprtorex ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 CytoPulse
2.8.1 Business Overview
2.8.2 ADME Toxicology Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CytoPulse ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Entelos
2.9.1 Business Overview
2.9.2 ADME Toxicology Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Entelos ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 LI-COR Biosciences
2.10.1 Business Overview
2.10.2 ADME Toxicology Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 LI-COR Biosciences ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Mattek
2.11.1 Business Overview
2.11.2 ADME Toxicology Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mattek ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Miltenyi Biotec
2.12.1 Business Overview
2.12.2 ADME Toxicology Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Miltenyi Biotec ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Molecular Toxicology
2.13.1 Business Overview
2.13.2 ADME Toxicology Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Molecular Toxicology ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Quintiles
2.14.1 Business Overview
2.14.2 ADME Toxicology Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Quintiles ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.15 RTI Health Solutions
2.15.1 Business Overview
2.15.2 ADME Toxicology Testing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 RTI Health Solutions ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.16 SBW
2.16.1 Business Overview
2.16.2 ADME Toxicology Testing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 SBW ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.17 Xenobiotic Detection Systems
2.17.1 Business Overview
2.17.2 ADME Toxicology Testing Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Xenobiotic Detection Systems ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.18 Xenometrix
2.18.1 Business Overview
2.18.2 ADME Toxicology Testing Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Xenometrix ADME Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global ADME Toxicology Testing Market Competition, by Players
3.1 Global ADME Toxicology Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 ADME Toxicology Testing Players Market Share
3.2.2 Top 10 ADME Toxicology Testing Players Market Share
3.3 Market Competition Trend
4 Global ADME Toxicology Testing Market Size by Regions
4.1 Global ADME Toxicology Testing Revenue and Market Share by Regions
4.2 North America ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
4.3 Europe ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
4.5 South America ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
5 North America ADME Toxicology Testing Revenue by Countries
5.1 North America ADME Toxicology Testing Revenue by Countries (2013-2018)
5.2 USA ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
5.3 Canada ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
6 Europe ADME Toxicology Testing Revenue by Countries
6.1 Europe ADME Toxicology Testing Revenue by Countries (2013-2018)
6.2 Germany ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
6.3 UK ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
6.4 France ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
6.5 Russia ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
6.6 Italy ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific ADME Toxicology Testing Revenue by Countries
7.1 Asia-Pacific ADME Toxicology Testing Revenue by Countries (2013-2018)
7.2 China ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
7.3 Japan ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
7.4 Korea ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
7.5 India ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
8 South America ADME Toxicology Testing Revenue by Countries
8.1 South America ADME Toxicology Testing Revenue by Countries (2013-2018)
8.2 Brazil ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue ADME Toxicology Testing by Countries
9.1 Middle East and Africa ADME Toxicology Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
9.3 UAE ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa ADME Toxicology Testing Revenue and Growth Rate (2013-2018)
10 Global ADME Toxicology Testing Market Segment by Type
10.1 Global ADME Toxicology Testing Revenue and Market Share by Type (2013-2018)
10.2 Global ADME Toxicology Testing Market Forecast by Type (2018-2023)
10.3 Toxicology Testing Revenue Growth Rate (2013-2023)
10.4 ADME Testing Revenue Growth Rate (2013-2023)
11 Global ADME Toxicology Testing Market Segment by Application
11.1 Global ADME Toxicology Testing Revenue Market Share by Application (2013-2018)
11.2 ADME Toxicology Testing Market Forecast by Application (2018-2023)
11.3 In Vivo Revenue Growth (2013-2018)
11.4 In Vitro Revenue Growth (2013-2018)
12 Global ADME Toxicology Testing Market Size Forecast (2018-2023)
12.1 Global ADME Toxicology Testing Market Size Forecast (2018-2023)
12.2 Global ADME Toxicology Testing Market Forecast by Regions (2018-2023)
12.3 North America ADME Toxicology Testing Revenue Market Forecast (2018-2023)
12.4 Europe ADME Toxicology Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific ADME Toxicology Testing Revenue Market Forecast (2018-2023)
12.6 South America ADME Toxicology Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa ADME Toxicology Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure ADME Toxicology Testing Picture
Table Product Specifications of ADME Toxicology Testing
Table Global ADME Toxicology Testing and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
